Babar Ghias - CFO & Head of Corp Development at Biocryst Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO & Head of Corp Development
Stock Symbol
BCRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Babar Ghias since 11/22/2024

Holdings reported by Babar Ghias for Biocryst Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 147K $1.52M $10.34 Jul 24, 2025 Direct
Emp. Stock Option (Right to Buy) 305K Jul 24, 2025 Direct Common Stock

Transactions reported by Babar Ghias for Biocryst Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.